Due to COVID-19 changes in service delivery have been made with immediate effect, until further notice. These changes have been made to enable us to continue to provide critical support to the COVID-19 diagnostic services and ensure business continuity. Turnaround times (TAT) of services which are currently maintained may be extended.
- Specialist testing for Cryptosporidium in immunocompromised patients at high risk: will continue by immunofluorescence microscopy on samples that are Cryptosporidium negative locally, and will be supplemented by the addition of a newly-validated real-time PCR-based test for Cryptosporidium spp.
- Confirmation of equivocal samples: will continue by immunofluorescence microscopy on samples with details of original test result
- Genotyping by PCR will continue but turnaround times will be longer
- Subtyping by PCR will not be undertaken unless a major outbreak occurs, then subject to discussion with Head of Unit or deputy
- Animal samples taken during a human outbreak will not be genotyped
- Genotyping services for water testing laboratories and water companies will be done in public health incidents/event and outbreaks only
- Positive control material will continue to be provided to laboratories on request
- Consultation advice will continue to be provided.